Skip to content
zameds

Oxazepam

Sold as Serepax forte, Serepax, Purata, Medopam, Zimtec, Adco-oxazepam, Noripam

S5
Loading the molecular structure
C15H11ClN2O2286.71 g/mol

7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one

Drag to rotate. Structure from PubChem CID 4616.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
5
Registrations
17
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Pharmacare limited û woodmead1 of 7 cancelledSerepax forte, Serepax, Purata, Noripam10 mg, 15 mg, 30 mgA0774, B1343, B1344, K0323, K0324, K0325, Y0070S5None
Alliance Pharma (Pty) LtdCancelledMedopam10, 15, 30Q0249, Q0250, Q0251S5None
Arya Pharma (Pty) LtdZimtec15, 30Q0292, Q0293S5None
Adcock ingram limited1 of 3 cancelledAdco-oxazepam10 mg, 15 mg, 30 mgU0112, U0113, U0114S5None
Viatris Healthcare (Pty) LtdNoripam10 mg, 15 mgY0068, Y0069S5None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Serepax forte

EACH TABLET CONTAINS OXAZEPAM 30 mg

Not listedA0774A/2.6/774RegisteredS5None
Serepax 10 MG

EACH TABLET CONTAINS OXAZEPAM 10 mg

10 mgB1343B/2.6/1343RegisteredS5None
Serepax 15 MG

EACH TABLET CONTAINS OXAZEPAM 15 mg

15 mgB1344B/2.6/1344RegisteredS5None
Purata - 10

EACH TABLET CONTAINS OXAZEPAM 10 MG

- 10K0323K/2.6/323RegisteredS5None
Purata - 15

EACH TABLET CONTAINS OXAZEPAM 15 MG

- 15K0324K/2.6/324RegisteredS5None
Purata - 30

EACH TABLET CONTAINS OXAZEPAM 30 MG

- 30K0325K/2.6/325RegisteredS5None
Medopam 10

EACH TABLET CONTAINS OXAZEPAM 10,0 mg

10Q0249Q/2.6/249CancelledS5None
Medopam 15

EACH TABLET CONTAINS OXAZEPAM 15 mg

15Q0250Q/2.6/250CancelledS5None
Medopam 30

EACH TABLET CONTAINS OXAZEPAM 30 mg

30Q0251Q/2.6/251CancelledS5None
Zimtec 15

EACH TABLET CONTAINS OXAZEPAM 15 MG OXAZEPAM 15 mg

15Q0292Q/2.6/292RegisteredS5None
Zimtec 30

EACH TABLET CONTAINS OXAZEPAM 30 mg

30Q0293Q/2.6/293RegisteredS5None
Adco-oxazepam tablets 10 mg*

EACH TABLET CONTAINS OXAZEPAM 10 mg

10 mgTabletsU0112U/2.6/112RegisteredS5None
Adco-oxazepam tablets 15 mg*

EACH TABLET CONTAINS OXAZEPAM 15 mg

15 mgTabletsU0113U/2.6/113RegisteredS5None
Adco-oxazepam tablets 30 mg*

EACH TABLET CONTAINS OXAZEPAM 30 mg

30 mgTabletsU0114U/2.6/114CancelledS5None
Noripam 10 MG

EACH TABLET CONTAINS OXAZEPAM 10 mg

10 mgY0068Y/2.6/68RegisteredS5None
Noripam 15 MG

EACH TABLET CONTAINS OXAZEPAM 15 mg

15 mgY0069Y/2.6/69RegisteredS5None
Noripam 30 MG

EACH TABLET CONTAINS OXAZEPAM 30 mg

30 mgY0070Y/2.6/70CancelledS5None

Regulatory status

Where S5 sits on the scale

Prescription-only, with tighter controls on repeats.

Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Oxazepam

  • S5: Oxazepam

    Consolidated Schedules 06 July 2026, line 9600

Pharmacological class: Tranquillisers. (class 2.6)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles